Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-23

Clinical Trial Update: Study on Use of Omega-3 Fatty Acids to Improve Outcomes in Individuals With Sickle Cell Disease [NA]

View source ↗

Summary

A clinical trial update notes a study evaluating omega-3 fatty acids to improve outcomes in individuals with sickle cell disease; the study is currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Sickle Cell Disease | NA | Status: ACTIVE_NOT_RECRUITING